Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENO1 | P06733 | 1/20 | 0.43 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | BRS3 | P32247 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.35 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 2/20 | 0.35 |
| ▸ | ACACA | Q13085 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23386772 | 0.89 | ENO1 (0.55) | ENO1HDAC6 | |
| SCHEMBL13607364 | 0.89 | ENO1 (0.55) | ENO1HDAC6 | |
| SCHEMBL23346071 | 0.81 | HDAC6 (0.40) | ENO1BRS3HDAC6 | |
| SCHEMBL24724733 | 0.80 | ALDH1A1 (0.46) | ENO1HDAC6 | |
| SCHEMBL21479645 | 0.77 | HDAC6 (0.40) | ENO1BRS3HDAC6ACACB | |
| SCHEMBL13607362 | 0.75 | ENO1 (0.60) | ENO1HDAC6 | |
| SCHEMBL2955788 | 0.73 | ADORA2A (0.43) | ADORA2AADORA1 | |
| SCHEMBL24933040 | 0.73 | LMNA (0.42) | — | |
| SCHEMBL13815210 | 0.71 | ENO1 (0.58) | ENO1HDAC6 | |
| SCHEMBL24724746 | 0.68 | CNR2 (0.37) | ENO1BRS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022235699-A2 | POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2022-11-10 | — | — | WO | disclosed |